Gritstone Oncology shares nearly quadruple after receiving NIH support on vaccine trial

Gritstone Oncology CEO Andrew Allen said the drugmaker hopes their potential coronavirus vaccine could help mitigate the spread of Covid-19 variants.

source https://www.cnbc.com/2021/01/20/gritstone-oncology-stock-run-triple-digits-after-nih-backs-vaccine-study.html

Post a Comment

0 Comments